RN Mobile Menu

Search form





Etanercept-szzs (Erelzi, Sandoz) has been approved by the U.S. Food and Drug Administration for RA and more.


A new report confirms that discounts for biosimilars do not determine global uptake and prescription incentives to encourage the use of biosimilars are hit and miss.


Biosimilars to Humira and Enbrel are one step closer to the marketplace with FDA advisory committee approval.

Seth Ginsberg

Global Healthy Living Foundation and CreakyJoints president and co-founder, Seth Ginsberg, cautions against extrapolation, but is optimistic about biosimilars.


ARD study recommends against biosimilar switching for patients positive for anti-infliximab (Remicade) antibodies.

In this slideshow, we summarize the approved indications for the rheumatology biosimilar Inflectra (infliximab-dyyb), the boxed warnings and possible side effects.


The U.S. approval of the first biosimilar in rheumatology, Inflectra, has been welcome news. Still, concerns about safety, interchangeability and costs dominate the discussions.


Subscribe to Biosimilars on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.